chemoprophylact
effect
paromomycin
sulfat
natur
cryptosporidiosi
young
kid
investig
two
studi
carri
use
two
group
anim
two
pen
pen
kid
alloc
treat
control
group
treatment
consist
oral
paromomycin
given
mg
kg
bodi
weight
day
consecut
day
day
age
kid
weigh
day
age
infect
monitor
collect
fecal
sampl
stain
fecal
smear
everi
day
day
day
result
clearli
show
efficaci
paromomycin
reduc
cryptosporidi
oocyst
output
moreov
paromomycin
prevent
clinic
sign
mortal
cryptosporidiosi
due
cryptosporidium
parvum
import
diseas
neonat
kid
anim
mainli
affect
second
third
week
life
clinic
sign
includ
acut
diarrhea
dehydr
day
progress
emaci
day
angu
morbid
may
approach
mortal
rang
yvore
et
al
thamsborg
et
al
besid
c
parvum
sever
agent
incrimin
neonatalkid
diarrhea
includ
escherichia
cob
rotaviru
coronaviru
adenoviru
gouet
drug
test
anticryptosporidi
activ
man
anim
five
effect
control
infect
without
caus
import
side
effect
alborixin
azithromycin
halofuginon
maduramycin
paromomycin
fayer
promis
result
obtain
paromomycin
cure
symptom
cryptosporidiosi
aid
patient
fichtenbaum
et
al
prevent
develop
c
paruum
experiment
infect
mice
calv
fayer
object
present
studi
test
paromomycin
prophylaxi
natur
infect
kid
french
dairi
goat
farm
farm
chosen
mortal
kid
reach
group
anim
day
age
novemb
examin
stain
fece
smear
ill
kid
reveal
numer
cryptosporidium
oocyst
goat
farm
locat
deuxsevr
western
franc
compris
alpin
herd
milk
rais
indoor
use
zerograz
system
kid
immedi
separ
dam
birth
receiv
two
feed
first
h
life
consist
ml
pool
goat
colostrum
follow
milk
replac
feed
contain
skim
milk
powder
distribut
multiteat
outlet
contain
februari
two
group
male
kid
select
group
anim
rear
pen
deep
litter
straw
bed
first
group
consist
kid
nine
born
februari
treat
paromomycin
nine
born
day
later
untreat
control
second
group
ii
born
day
week
later
divid
treat
n
control
n
kid
use
random
number
gener
treatment
conduct
farmer
paromomycin
sulfat
humfiel
enfant
parkedavi
franc
total
daili
dose
rate
mg
kg
bodi
weight
sw
consecut
day
begin
day
age
fayer
elli
powder
drug
dispens
water
given
oral
syring
two
daili
dosag
fece
sampl
individu
taken
rectal
curett
everi
day
day
day
demonstr
oocyst
made
stain
fecal
smear
ziehl
fuchsin
observ
x
magnif
phasecontrast
microscop
accord
hein
oocyst
number
score
semiquantit
scale
oocyst
less
one
oocyst
per
field
oocyst
oocyst
oocyst
oocyst
presenc
absenc
diarrhea
record
blind
farmer
wife
daili
basi
kid
weigh
age
day
standon
scale
g
comparison
weight
mean
daili
weight
gain
group
made
onetail
mannwhitney
test
level
confid
set
kid
first
group
nine
untreat
kid
show
persist
diarrhea
day
day
cryptosporidi
oocyst
output
peak
day
anim
oocyst
score
point
tabl
five
kid
die
day
day
day
three
four
remain
kid
maintain
low
oocyst
excret
contrast
medic
kid
show
transient
diarrhea
day
four
anim
low
oocyst
output
score
day
day
five
kid
oocyst
count
zero
day
day
treat
anim
neg
cryptosporidi
oocyst
output
mortal
record
day
day
mean
daili
bodi
weight
gain
control
kid
impair
compar
medic
kid
g
vs
g
differ
statist
signific
second
group
neither
control
medic
kid
show
persist
diarrhea
pattern
oocyst
excret
mortal
control
kid
second
trial
similar
first
group
output
peak
day
two
mortal
day
tabl
three
seven
medic
kid
oocyst
excret
score
one
die
end
survey
day
growth
control
kid
inferior
medic
kid
throughout
studi
mean
daili
bodi
weight
gain
day
g
vs
g
differ
signific
eight
kid
die
two
trial
necropsi
except
medic
kid
second
trial
anim
show
distens
small
larg
intestin
tabl
comparison
cryptosporidi
oocyst
shed
score
treat
paromomycin
day
day
age
untreat
kid
trial
treat
group
kid
number
untreat
group
kid
number
yellow
pasti
content
lesion
encount
escherichiu
coli
strain
isol
small
intestin
liver
identifi
experi
shown
administr
paromomycin
day
day
birth
strongli
reduc
complet
prevent
cryptosporidi
oocyst
output
natur
expos
kid
moreov
first
group
anim
control
kid
sever
affect
paromomycin
prevent
diarrhea
mortal
end
studi
day
oocyst
excret
medic
anim
differ
control
result
agreement
fayer
elli
obtain
calv
experiment
infect
c
parvum
oocyst
treat
paromomycin
mg
kg
bw
consecut
day
lower
dosag
mg
kg
bw
calv
began
shed
oocyst
day
start
treatment
sever
diarrhea
less
control
anim
fayer
elli
paromomycin
oral
administ
aminoglycosid
antibiot
produc
streptomyc
pauciti
advers
effect
man
clezi
et
al
high
ld
e
mice
mg
kg
oral
may
attribut
lack
system
absorpt
result
seem
indic
least
treat
anim
studi
paromomycin
well
toler
addit
poor
absorpt
may
lead
limit
distribut
paromomycin
residu
kid
organ
thu
short
meat
withdraw
time
aspect
concern
franc
dairygoat
farmer
produc
commerci
kid
slaughter
earli
age
day
one
limit
factor
use
paromomycin
besid
work
constraint
could
cost
drug
avail
veterinari
use
franc
administr
human
medicin
packag
paromomycin
kid
day
expens
french
franc
repres
kid
gross
margin
howev
case
replac
femal
kid
high
cost
less
concern
halofuginon
lactat
reduc
clinic
sign
oocyst
output
rumin
naciri
yvorc
villacorta
et
al
recent
studi
conduct
calv
pg
kg
day
experiment
condit
naciri
et
al
duplic
kid
field
condit
compar
paromomycin
prophylaxi
schedul
order
defin
effect
conveni
way
control
cryptosporidiosi
goat
although
cryptosporidi
infect
probabl
present
adult
goat
low
level
demonstr
adult
cattl
sheep
lorenzo
lorenzo
et
al
xiao
et
al
chemic
control
cryptosporidi
oocyst
output
neonat
result
reduct
environment
contamin
thu
potenti
transmiss
infect
human
smith
